Aksoy Mark O, Mardini Issam A, Yang Yi, Bin Wei, Zhou Shuangwen, Kelsen Steven G
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Temple University School of Medicine, Philadelphia, PA, USA.
J Allergy Clin Immunol. 2002 Mar;109(3):491-7. doi: 10.1067/mai.2002.122154.
Activation of the beta(2)-adrenergic receptor (beta(2)AR) system expressed by human airway epithelial cells elicits a variety of cyclic adenosine monophosphate (cAMP)-dependent processes that help determine airway caliber and the intensity of airway inflammation in asthma. Glucocorticoids, mainstays in the treatment of asthma, profoundly affect the expression and function of the beta(2)-adrenergic receptor-adenylyl cyclase (beta(2)AR-AC) system in a variety of cell types. However, the effects of glucocorticoids on the beta(2)AR-AC system expressed by human airway epithelial cells are unstudied.
We examined the effects of dexamethasone (DEX) on beta(2)AR gene expression and the function of the beta(2)AR-AC system in cultured human airway epithelial cells.
Studies were performed in normal airway epithelial cells and BEAS-2B cells. Beta(2)AR gene expression was assessed from measurements of beta-adrenergic receptor density, beta(2)AR mRNA, and the activity of a full-length beta(2)AR promoter-luciferase reporter construct. The function of the beta(2)AR-AC system was assessed from cAMP production in response to the beta(2)-agonist isoproterenol and the expression of the stimulatory G protein G(alpha)s.
DEX had no effect on beta-adrenergic receptor density or on the beta(1)/beta(2) ratio over a wide range of concentrations and exposure times. However, DEX significantly but transiently enhanced beta(2)AR mRNA levels (approximately 1.5-fold) and beta(2)AR promoter activity (approximately 1.5-fold), indicating increased beta(2)AR gene transcription. DEX also dose-dependently enhanced cAMP responses to isoproterenol but not to forskolin, a direct activator of adenylyl cyclase. DEX-induced changes in cAMP production were associated with small (approximately 15%) increases in G(alpha)s expression.
These data indicate that glucocorticoids only transiently enhance beta(2)AR gene transcription and fail to increase steady-state levels of beta(2)AR protein in human airway epithelial cells. Nonetheless, glucocorticoid-induced effects on the beta(2)AR-AC system of human airway epithelial cells contribute to the beneficial effects of corticosteroids in asthma by enhancing the functional response to beta(2)-agonists.
人气道上皮细胞表达的β₂ - 肾上腺素能受体(β₂AR)系统的激活引发多种环磷酸腺苷(cAMP)依赖性过程,这些过程有助于确定哮喘患者的气道管径和气道炎症强度。糖皮质激素是哮喘治疗的主要药物,可深刻影响多种细胞类型中β₂ - 肾上腺素能受体 - 腺苷酸环化酶(β₂AR - AC)系统的表达和功能。然而,糖皮质激素对人气道上皮细胞表达的β₂AR - AC系统的影响尚未得到研究。
我们研究了地塞米松(DEX)对培养的人气道上皮细胞中β₂AR基因表达及β₂AR - AC系统功能的影响。
在正常气道上皮细胞和BEAS - 2B细胞中进行研究。通过测量β - 肾上腺素能受体密度、β₂AR mRNA以及全长β₂AR启动子 - 荧光素酶报告基因构建体的活性来评估β₂AR基因表达。通过响应β₂ - 激动剂异丙肾上腺素产生的cAMP以及刺激性G蛋白Gαs的表达来评估β₂AR - AC系统的功能。
在广泛的浓度范围和暴露时间内,DEX对β - 肾上腺素能受体密度或β₁/β₂比值没有影响。然而,DEX显著但短暂地提高了β₂AR mRNA水平(约1.5倍)和β₂AR启动子活性(约1.5倍),表明β₂AR基因转录增加。DEX还剂量依赖性地增强了对异丙肾上腺素的cAMP反应,但对腺苷酸环化酶的直接激活剂福斯可林无此作用。DEX诱导的cAMP产生变化与Gαs表达小幅(约15%)增加有关。
这些数据表明,糖皮质激素仅短暂增强人气道上皮细胞中β₂AR基因转录,而未能增加β₂AR蛋白的稳态水平。尽管如此,糖皮质激素对人气道上皮细胞β₂AR - AC系统的诱导作用通过增强对β₂ - 激动剂的功能反应,有助于皮质类固醇在哮喘治疗中的有益作用。